206 related articles for article (PubMed ID: 21696088)
1. Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis.
Apasrawirote W; Udompataikul M; Rattanamongkolgul S
J Med Assoc Thai; 2011 Jun; 94(6):756-60. PubMed ID: 21696088
[TBL] [Abstract][Full Text] [Related]
2. Topical antifungals for seborrhoeic dermatitis.
Okokon EO; Verbeek JH; Ruotsalainen JH; Ojo OA; Bakhoya VN
Cochrane Database Syst Rev; 2015 May; (5):CD008138. PubMed ID: 25933684
[TBL] [Abstract][Full Text] [Related]
3. Role of antifungal agents in the treatment of seborrheic dermatitis.
Gupta AK; Nicol K; Batra R
Am J Clin Dermatol; 2004; 5(6):417-22. PubMed ID: 15663338
[TBL] [Abstract][Full Text] [Related]
4. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
Gupta AK; Versteeg SG
Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089
[TBL] [Abstract][Full Text] [Related]
5. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
Elewski B; Ling MR; Phillips TJ
J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
Seckin D; Gurbuz O; Akin O
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox gel for seborrheic dermatitis of the scalp.
Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
Lebwohl M; Plott T
Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
[TBL] [Abstract][Full Text] [Related]
10. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
Abeck D;
Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
Diehl C; Ferrari A
J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
[TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis.
Piérard-Franchimont C; Piérard GE
Dermatology; 2002; 204(4):344-7. PubMed ID: 12077544
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.
Starova A; Aly R
Expert Opin Drug Saf; 2005 Mar; 4(2):235-9. PubMed ID: 15794716
[TBL] [Abstract][Full Text] [Related]
14. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.
Gupta AK; Nicol KA
Int J Dermatol; 2006 Jan; 45(1):66-9. PubMed ID: 16426382
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
Altmeyer P; Hoffmann K;
Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
Shuster S; Meynadier J; Kerl H; Nolting S
Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
[TBL] [Abstract][Full Text] [Related]
17. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
[TBL] [Abstract][Full Text] [Related]
18. Topical ketoconazole: a systematic review of current dermatological applications and future developments.
Choi FD; Juhasz MLW; Atanaskova Mesinkovska N
J Dermatolog Treat; 2019 Dec; 30(8):760-771. PubMed ID: 30668185
[No Abstract] [Full Text] [Related]
19. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
[TBL] [Abstract][Full Text] [Related]
20. Seborrheic dermatitis.
Gupta AK; Bluhm R; Cooper EA; Summerbell RC; Batra R
Dermatol Clin; 2003 Jul; 21(3):401-12. PubMed ID: 12956195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
